期刊文献+

临床干预研究中结局指标的选择方法 被引量:22

Methods of selecting outcome variables for clinical intervention
暂未订购
导出
摘要 临床干预研究对结局指标的选择有两个阶段,分别为收集与优选,其方法有头脑风暴法、德尔菲法、哥顿法、系统评价、系统分析法及建立数学模型等。每种方法都有各自的优缺点。对于临床诊断治疗性干预研究,应根据研究的目的、指标的代表性、敏感性等,综合选择所推荐的各种方法。 There are two stages for selecting the clinical intervention outcome variables. One is crude collection and the other is precise collection. The selection methods include brainstorming method, Delphi method, Gordon method, systematic review, systematic analysis method, mathematic model method and so on. Each method has some advantages or disadvantages. When selecting the clinical intervention outcome variables, researchers should make sure the research aim, the representative and the sensitivity of the variables, and select all kinds of recommended methods comprehensively, then decide which method should be used.
出处 《中西医结合学报》 CAS 2007年第1期11-14,共4页 Journal of Chinese Integrative Medicine
基金 科技部十五攻关资助项目(No.2004BA716B04)
关键词 临床研究 干预性研究 结果评价 方法 clinic studies intervention studies outcome assessments methods
  • 相关文献

参考文献5

二级参考文献21

  • 1Psaty BM, Weiss NS, Furberg CD, et al. Surrogate end points, health outcomes and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA.1999 ;282(8): 786-790.
  • 2Johnston K. What are surrogate outcome measures and why do they fail in clinical research? Neuroepidemiology 1999; 18(4): 167-173.
  • 3The Cochrance Reviewer' Handbook Glossary (Version 4.1.4), 26-27. The Cochrane Collaboration 2001.
  • 4Chuang-Stein C, DeMasi R. Surrogate endpoints in AIDS drug development: current status. Drug Information J 1998;32: 439-448, 457-459.
  • 5Gould AL. Discussion of "Surrogate endpoints in AIDS drug evelopment: current status" by C. Chuang-Stein and Ralph DeMasi. Drug Information J 1998 ;32: 453-456.
  • 6Hill AM, DeMasi R, Dawson D. Meta-analysis of antiretroviral effects on HIV-1 RNA, CD4 cell count and progression to AIDS or death. Antivir Ther 1998 ;3(3) :139-145.
  • 7Ellenberg SS. Commentary on "Surrogate endpoints in AIDS drug development: current status"by C. chuang-stein and R.DeMasi. Drug Information J 1998;32:453-456.
  • 8Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355(9200): 253-259.
  • 9Echt DS, Leibson PR, Mitchel LB, et al. Cardiac arrhythmia suppression trial. N Engl J Med. 1989 ;321:406.
  • 10Fleming TR, De Mets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med, 1996; 125 (7):605-613.

共引文献200

同被引文献225

引证文献22

二级引证文献162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部